← Back to Analyst Consensus 
INBX Buy
Inhibrx Biosciences, Inc.
Current Price —
Implied Upside —
Analysts 10
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 13, 2026 (17 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 24, 2026 | HC Wainwright & Co. | initiate | — → Buy | — | 44% |
| Apr 8, 2026 | Stifel | initiate | — → Buy | — | 54% |
| Aug 22, 2025 | JMP Securities | reiterate | Market Perform → Market Perform | $0 | 53% |
| May 15, 2025 | JMP Securities | reiterate | Market Perform → Market Perform | $0 | 53% |
| Mar 18, 2025 | Citizens Capital Markets | reiterate | Market Perform → Market Perform | $0 | 49% |
| Jan 22, 2025 | JMP Securities | reiterate | Market Perform → Market Perform | $0 | 53% |
| Jul 23, 2024 | JMP Securities | initiate | — → Market Perform | $0 | 53% |
| Jan 23, 2024 | JMP Securities | downgrade | Market Outperform → Market Perform | $0 | 53% |
| Nov 20, 2023 | JMP Securities | reiterate | Market Outperform → Market Outperform | $27 | 53% |
| Aug 23, 2023 | JMP Securities | maintain | Outperform → Outperform | $27 | 53% |
| May 10, 2023 | JMP Securities | reiterate | — → Market Outperform | $35 | 53% |
| Mar 8, 2023 | JMP Securities | maintain | — → Market Outperform | $35 | 53% |
| Mar 7, 2023 | Credit Suisse | reiterate | — → Outperform | $46 | — |
| Nov 8, 2022 | Credit Suisse | maintain | — → Outperform | $46 | — |
| Oct 5, 2022 | Evercore ISI Group | maintain | — → Outperform | $60 | 58% |
| Aug 9, 2022 | Credit Suisse | maintain | — → Outperform | $48 | — |
| Mar 16, 2022 | SMBC Nikko | initiate | — → Outperform | $40 | — |
| Mar 2, 2022 | JMP Securities | maintain | — → Market Outperform | $40 | 53% |
| Nov 10, 2021 | Credit Suisse | maintain | — → Outperform | $53 | — |
| Nov 2, 2021 | JMP Securities | maintain | — → Market Outperform | $53 | 53% |
| Sep 21, 2021 | JMP Securities | initiate | — → Market Outperform | $46 | 53% |
| Sep 14, 2020 | Jefferies | initiate | — → Buy | $30 | 52% |
| Sep 14, 2020 | Evercore ISI Group | initiate | — → Outperform | $30 | 58% |
| Sep 14, 2020 | Credit Suisse | initiate | — → Outperform | $26 | — |
Price Target Trend
Apr 21, 2026 Oct 26, 2026
EPS Estimates
+1y —
0y —
+1q —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days